Business Insider11h
Novo Nordisk’s Ozempic® Gains EMA Positive Opinion for Kidney Disease Risk Reduction
Pick the best stocks and maximize your portfolio: Novo Nordisk ( (NVO)) has provided an update. Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human ...
FiercePharma4h
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to ...
Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.
Novo Nordisk’s blockbuster drug Ozempic got another star added to its label Thursday, in an encouraging sign for the ...
FierceBiotech22h
Evotec, Novo Nordisk's drug discovery accelerator debuts first 3 projects, adds 5 partners
LAB eN 2, the drug discovery accelerator launched by Evotec and Novo Nordisk in September 2023, has unveiled its first three ...
Ozempic Link to Rare Vision Loss Risk Confirmed in Large Trial
Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that ...
Bloomberg L.P.20h
Novo Nordisk A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...